To bridge this gap, we systematically examined the role of PICH in lung cancer through clinical analysis, in vitro experiments, and in vivo primary tumour model to thoroughly examine PICH's involvement in lung cancer and evaluate its potential for therapeutic intervention. This evidence concerns the gene ERCC6L and lung cancer.